Vir Biotechnology Inc
Change company Symbol lookup
Select an option...
VIR Vir Biotechnology Inc
$NQUSB40401010N Nasdaq US Benchmark Diversified Reta
IVZ Invesco Ltd
SPLK Splunk Inc
TW Tradeweb Markets Inc
CMPGY Compass Group PLC
DZSI DZS Inc
FCPT Four Corners Property Trust Inc
UGI UGI Corp
BMI Badger Meter Inc
Go

Health Care : Biotechnology | Small Cap Growth

Vir Biotechnology, Inc. is a commercial-stage immunology company focused on combining immunologic insights with technologies to treat and prevent serious infectious diseases. It has assembled four technology platforms focused on antibodies, T cells, innate immunity, and small interfering ribonucleic acid (siRNA), through internal development, collaborations, and acquisitions. The Company's pipeline consists of sotrovimab and other product candidates targeting COVID-19, hepatitis B virus (HBV), influenza A virus, and human immunodeficiency virus (HIV). Its product candidates include Sotrovimab and VIR-7832, VIR-2218, VIR-3434, VIR-2482, VIR-1111. It is engaged in developing differentiated monoclonal antibodies (mAbs) as well as vaccines and small molecules that focuses is on treating and preventing severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2). VIR-2218 and VIR-3434, are for the treatment of HBV. VIR-2482 is an investigational IM administered influenza A-neutralizing mAb.

Postmarket

Last Trade: Delayed
$30.00

Change Since Close Change Since Close Postmarket extended hours change is based on the last price at the end of the regular hours period. Premarket extended hours change is based on the day's regular session close.: -0.14 (-0.46%)

Bid: --

Ask: --

B/A Size: --

Market Hours

Closing Price: $30.14

Day's Change: 0.23 (0.77%)

Bid close: --

Ask close: --

B/A Size: --

Day's High: 30.95

Day's Low: 29.35

Volume (Average) Volume: 859,260 10-day average volume: 895,288: 859,260

EBay stock price target cut to $43 from $56 at Deutsche Bank

8:34 am ET October 25, 2022 (MarketWatch) Print

(END) Dow Jones Newswires

October 25, 2022 08:34 ET (12:34 GMT)

Market data accompanied by is delayed by at least 15 minutes for NASDAQ, NYSE MKT, NYSE, and options. Duration of the delay for varies.

Market data and information provided by Morningstar.

Options are not suitable for all investors as the special risks inherent to options trading may expose investors to potentially rapid and substantial losses.
Please read Characteristics and Risks of Standard Options before investing in options.

Information and news provided by ,, , Computrade Systems, Inc., ,, and

Postmarket

Change Since Close

Market Hours